<DOC>
	<DOCNO>NCT02396706</DOCNO>
	<brief_summary>Randomized , control , double-blind , multi-center trial evaluate efficacy safety liquid contain ivy leaf dry extract vs. placebo treatment acute cough</brief_summary>
	<brief_title>RCT Evaluate Efficacy Safety Ivy Leaves Cough Liquid v . Placebo Treatment Acute Cough</brief_title>
	<detailed_description />
	<mesh_term>Cough</mesh_term>
	<criteria>1 . Acute cough symptom last 23 day prior treatment 2 . Men woman ethnic origin 3 . Age 18 75 year 4 . Subjects able understand willing comply trial instruction 5 . Having give write informed consent 6 . Satisfactory health except cough determine investigator base medical history physical examination 7 . CS score least 50 mm 100 mm VAS V1 8 . Acute BSS least 10 point V1 9 . VCD score least 2 point V1 1 . Allergic bronchial asthma , bronchial hyperreactivity , chronic bronchitis , chronic inherit lung disease 2 . History hypersensitivity excipient apply drug 3 . History drug hypersensitivity , asthma , urticaria , severe allergic diathesis well current hay fever 4 . History chronic gastritis peptic ulcer 5 . Any gastrointestinal complaint within 7 day V1 6 . Participation clinical trial within 30 day prior treatment phase study concomitantly 7 . Treatment corticoid , beta2 agonist ( e.g . salbutamol , fenoterol ) , expectorant , theophylline , antitussive , anaesthetic , acetylsalicylic acid ( e.g . aspirin ) nonsteroidal antiinflammatory drug , leukotriene inhibitor , angiotensinconverting enzyme ( ACE ) inhibitor , antiviral drug antibiotic , antihistamine , immunosuppressant , isoprenaline , atropine , sodium cromoglycate homeopathic drug common cold within 7 day V1 8 . Drug alcohol abuse opinion investigator 9 . Pregnant nursing ( lactate ) woman 10 . Women childbearing potential ( defined woman physiologically capable become pregnant ) use acceptable method contraception . 11 . Subjects significant disease , define disease , opinion investigator , may either put subject risk participation trial disease may influence result trial subject 's ability participate trial ; include subject history gastrointestinal bleeding , significant cardiovascular , liver renal disease . 12 . Subjects directly indirectly involved execution protocol , include employee CRO person relate .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>September 2015</verification_date>
</DOC>